Abstract 798: Pathway-directed high-throughput drug screen identifies PI3K inhibitors that synergistically potentiate antitumor activity of HDAC inhibitors in cutaneous T-cell lymphomaChi-Heng Wu, Weiyun Z. Ai, Taha Rakhshandhroo et al.|Cancer Research|2018Cited by 0